当前位置 : X-MOL首页行业资讯 › 亚利桑那大学Jianqin Lu课题组招多名药物化学/纳米医学博士后及多名全奖药剂学博士

亚利桑那大学Jianqin Lu课题组招多名药物化学/纳米医学博士后及多名全奖药剂学博士

lujianqin-1.png

Dr. Lu is a John A. and Frances P. Ware Endowed Associate Professor and the Director of Pharmaceutics and Pharmacokinetics Track at R. Ken Coit College of Pharmacy, one of the premier Pharmacy Schools (ranked No. 4 by American Association of Colleges of Pharmacy), at the University of Arizona (UArizona), a member of the Association of American Universities (AAU), a distinction to only 69 North America's premier research institutions. UArizona had more than $955 million total R&D expenditures in 2023, which ranked No. 36 in US by NSF Higher Education Research and Development (HERD) Survey  (https://ncsesdata.nsf.gov/profiles/site?method=rankingBySource&ds=herd  ). 


The overarching goal of the Lu lab strives to develop innovative, safe, and efficacious therapeutics at the interface of drug discovery and delivery, synthetic chemistry, pharmaceutics, nanotechnology, and tumor immunology to address the pressing unmet needs in current cancer, heart, and Alzheimer's diseases therapy and prevention. 


Dr. Lu’s research work has been published in Nature Cancer, Nature Nanotechnology, Nature Communications etc, and has secured > $9 Million research funding including a Maximizing Investigators' Research Award (MIRA) (R35) and 2 R01 grants from the National Cancer Institute of NIH, UArizona Startup and Retention Funds, and other grants from PhRMA Foundation, State of Arizona, UArizona Comprehensive Cancer Center, etc. Visit Lu lab website at: https://www.pharmacy.arizona.edu/person/jianqin-lu and https://wonderfulearth.wixsite.com/jianqinlu 


Recent Representative Publications:

1. Wang, Z., …, Lu, J*. Nature Cancer. In press (2025)

2. Wang, Z#., Li, W#., …, Lu, J*. Nature Communications. 15, 2073 (2024)

3. Wang, Z., …, Lu, J*. Nature Communications. 14, 7235, (2023)

4. Wang, Z., …, Lu, J*. Nature Nanotechnology. 16, 1130–1140 (2021)

4 Postdoctoral Research Associate are available immediately. Candidates should have a strong track record in medicinal chemistry, pharmaceutics, drug delivery, nanomedicine, or immunology.  

2 PhD students with full scholarship is available immediately. Candidates should have training in medicinal chemistry, pharmaceutics, drug delivery, nanomedicine, or pharmacology. Candidates with first author publication(s) in related fields is preferable.

Applicants should send cover letter and CV to Dr. Lu at lu6@arizona.edu



如果篇首注明了授权来源,任何转载需获得来源方的许可!如果篇首未特别注明出处,本文版权属于 X-MOLx-mol.com ), 未经许可,谢绝转载!

阿拉丁
锁定材料科学TOP学者科研动态
第二届Wiley新锐科学家奖
Chemistry Europe
加速出版服务0811
期刊文稿免费评分工具
第八届高分子科学前沿国际研讨会
爱思唯尔主办第26届四面体研讨会
上传手稿,智能选刊
心脏病学SCI国际期刊
医学期刊征稿
开放获取内容中心上线
molecular中国科学院期刊分区2025生物学大类一区
EMBO中国科学院期刊分区2025医学大类一区
EMBO中国科学院期刊分区2025生物学大类-区
中国科学院期刊分区
综合医学期刊
生物医药期刊
文章Top榜单
教育领域多学科期刊
加速出版服务新
Springer旗下全新催化方向高质新刊
系统生物学合成生物学
专注于基础生命科学与临床研究的交叉领域
传播分子、细胞和发育生物学领域的重大发现
聚焦分子细胞和生物体生物学
快速找到合适的投稿机会
热点论文一站获取
定位全球科研英才
中国图象图形学学会合作刊
南科大
浙江大学
东方理工
重庆大学
国科大
华中师范
rice
哈尔滨
华南理工
rice
ACS材料视界
down
wechat
bug